Interestingly, we found lower serum sPD-L1 levels in patients who recovered from COVID-19 as compared with both healthy controls and patients with COVID-19 (Figure 3H), suggesting an overstimulation of the PD-1/PD-L1 axis in these patients. This evidence concerns the gene SPDL1 and COVID-19.